|Titre :||Indicated prevention for college student marijuana use: A randomized controlled trial (2013)|
|Auteurs :||C. M. LEE ; J. R. KILMER ; C. NEIGHBORS ; D. C. ATKINS ; C. ZHENG ; D. D. WALKER ; M. E. LARIMER|
|Type de document :||Article : Périodique|
|Dans :||Journal of Consulting and Clinical Psychology (Vol.81, n°4, August 2013)|
|Article en page(s) :||702-709|
|Discipline :||PRE (Prévention / Prevention)|
Thésaurus TOXIBASEPREVENTION ; CANNABIS ; ETUDE RANDOMISEE ; MILIEU SCOLAIRE ; INTERVENTION BREVE ; ADULTE JEUNE ; MOTIVATION ; EVALUATION
Objective: Marijuana is the most frequently reported illicit substance used on college campuses. Despite the prevalence, few published intervention studies have focused specifically on addressing high-risk marijuana use on college campuses. The present study evaluated the efficacy of an in-person brief motivational enhancement intervention for reducing marijuana use and related consequences among frequently using college students.
Method: Participants included 212 college students from 2 campuses who reported frequent marijuana use (i.e., using marijuana at least 5 times in the past month). Participants completed Web-based screening and baseline assessments and upon completion of the baseline survey were randomized to either an in-person brief intervention or an assessment control group. Follow-up assessments were completed approximately 3 and 6 months post-baseline. Marijuana use was measured by number of days used in the past 30 days, typical number of joints used in a typical week in the last 60 days, and marijuana-related consequences.
Results: Results indicated significant intervention effects on number of joints smoked in a typical week and a trend toward fewer marijuana-related consequences compared with the control group at 3-month follow-up.
Conclusion: This study provides preliminary data on short-term effects of a focused marijuana intervention for college students at reducing marijuana use during the academic quarter.
|Domaine :||Drogues illicites / Illicit drugs|
Department of Psychiatry and Behavioral Sciences, University of
Washington, Seattle, WA, USA